Dual infection with chikungunya and parvovirus B19: Cross-sectional study in northeast India
Transcript of Dual infection with chikungunya and parvovirus B19: Cross-sectional study in northeast India
i n d i a n j o u r n a l o f r h e uma t o l o g y 9 ( 2 0 1 4 ) S 7eS 6 7S58
P174. Endocarditis in a rheumatology unit e blurring thedistinction between autoimmunity and infection!
Durga Prasanna Misra, Abhra Chandra Chowdhury,
Sukesh Edavalath, Ramnath Misra, Amita Aggarwal,
Able Lawrence, Vikas Agarwal; Department of Clinical Immunology,Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow,India
Introduction: Rheumatic manifestations can be present in greater
than a third of patients with infective endocarditis (IE). These
symptoms can predate the diagnosis of IE by many months.
Methods: We reviewed the diagnoses at discharge in a tertiary
care Rheumatology and Clinical Immunology unit over a period of
1 year (February 2013 to January 2014) for patients with IE.
Results: We identified 6 patients with endocarditis (0.55%) out of a
total of 1089 discharges.
Serial No. Age Sex Presentation Mimicking which rheumatic disease Valve involved Organism isolated
1 63 Female Symmetric inflammatory
polyarthritis
Seronegative rheumatoid arthritis Tricuspid Methicillin-resistant
Staphylococcus aureus
2 27 Female Limb claudication and
absent upper limb pulses
Takayasu's arteritis Mitral Negative
3 34 Male Fever, active urinary sediment,
jejunal artery aneurysm with
high anti-PR3 titres
ANCA-associated vasculitis Mitral Methicillin-sensitive
Staphylococcus aureus
4 25 Female Pulmonary-renal syndrome
following abortion
ANCA-associated vasculitis Tricuspid Negative
5 49 Female Fever, polyarthritis and
bullous skin lesions
Gonococcal arthritis Aortic Escherichia coli and
Pseudomonas
6 31 Male Fever and pancytopenia Systemic lupus erythematosus Aortic Enterococcus
Conclusion: This case series serves to emphasise varied pre-
sentations of endocarditis as mimics of rheumatic diseases, and
highlights the need to be aware of such unusual presentations.
P175. Dual infection with chikungunya and parvovirus B19:Cross-sectional study in northeast India
Sakir Ahmeda, Sanjeeb Kakatia, Lahari Saikiab; aDepartment ofInternal Medicine and bDepartment of Internal Medicine andMicrobiology, Assam Medical College, Dibrugarh, India
Introduction: Interplay between microbes and immunity sculp-
tures autoimmunity. Parvovirus B19 has been implicated in
various autoimmune conditions. Chikungunya is causing a
pandemic of debilitating arthritis, indistinguishable from Rheu-
matoid Arthritis in its chronic form. Literature searches revealed
only 6 cases of chikungunya reported from Northeast India
excluding Meghalaya, and no Parvovirus B19 reported from
Northeast India.
Methods: All consenting patients with acute polyarthritis or an
acute exacerbation of chronic arthritis were enrolled. De-
mographic profile, pattern of joint involvement, functional status
(WHO-HAQDI), disease activity indices and extra-articular mani-
festations were recorded. IgM ELISAs for both Chikungunya and
Parvovirus B19 were performed.
Results: We obtained 49 cases of IgM positive Parvovirus B19, the
first series to be reported from Northeast India. Chikungunya IgM
was positive in 31 cases. 14 cases had dual infection- a phenom-
enon that we have not found reported anywhere worldwide.
Out of total 140 cases, 49 were acute though virus positivity was
equal among acute and chronic cases. The positive cases reported
more of joint erythema though not statistically significant. Three
parvovirus cases had skin rash. No other parameter was different
between virus positive and negative cases. Dual infection did not
significantly alter clinical presentation, arthritis severity or func-
tional status.
Conclusion: Contrary to contemporary beliefs, Chikungunya is
prevalent in Northeast India. Acute parvoviral infection is also
present. Dual infection by these two viruses is being reported for
the first time. The long-term implications of these infections in
Northeast India need further evaluation.
P176. Reactive arthritis: Is it a forerunner ofspondyloarthropathy
Hema M.a, Kavitha M.M.b, Theresa Maryc, S. Balameenab,
Rajeswari S.b; aStanley Medical College, India; bDepartments ofRheumatology and cImmunology, Madras Medical College, India
Aim and Objective: To study the correlation of serum levels of IL
17A and the disease activity of Reactive arthritis and its
outcome.
Methods: Patients who satisfied the “BERLIN” criteria for reactive
arthritis were chosen and followed up. Their disease activity was
assessed at the onset, 6 months and 1 year using DAREA score .CT
sacroiliac joints was taken at the onset and after 1 year .serum
IL17A levels were analysed at the end of 1 year by ELISA.
Results: Among the 46 patients, IL 17A levels were elevated in 22
patients . DAREA score was high in patients with elevated IL17A
levels at the onset, 6 months and the end of 1year. Among IL17A
positive patients 8 developed clinically and radiologically evident
axial spondyloarthropathy and 12 patients developed chronic
reactive arthritis.2 patients went in for remission.
Discussion: IL17A levels were significantly elevated in about
47.8% of our patients of reactive arthritis. Patients who had high
and persistence disease activity had high titres .Even though
IL17A had no statistical significance with spondyloarthropathy